Latest Standards Updates
Nine New Revision Bulletins (posted 18–Dec–2020)
Three New Pending Notice of Intent to Revise (posted 18–Dec–2020)
Two New Notices of Intent to Revise (posted 18–Dec–2020)
One Updated Notice of Intent to Revise (posted 18–Dec–2020)
One Updated General Announcement (posted 11–Dec–2020)
Cumulative List Available (updated 18–Dec–2020)
200 years of building trust
The United States Pharmacopeia (USP) was created nearly 200 years ago, dedicated to instilling trust where it matters most: in the medicines, supplements and foods people rely on for their health. The quality standards we develop help manufacturers deliver on their promises of safe products, while building confidence among healthcare practitioners, patients and consumers.
FDA Commissioner welcomes USP Convention Members
Commissioner Hahn reflects on the FDA’s shared history with USP to improve public health and protect patient safety, including current efforts to combat COVID-19.
Ignore the politics. Trust the science
Recent politicization of the COVID-19 vaccine development and approval process has led to a concerning loss of confidence in vital governmental institutions designed to protect the public from harm.